Blood Pressure
Blood Pressure Measurement Technique
- Sphygmomanometer (see Sphygmomanometer)
- Allows Nonivasive Measurement of Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)
- Noninvasive Cuff Measurement of Blood Pressure (Especially Automated Cuff Measurement) is Less Accurate in Shock States (JAMA, 1967) [MEDLINE]
- Arterial Line (see Arterial Line)
- Allows Invasive Measurement of Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)
- Arterial Line Placement with Invasive Blood Pressure Measurement is Generally Recommended in the Setting of Shock (Especially When Vasopressors are Required)
Equation for the Mean Arterial Pressure (MAP)
- MAP = [(2 x DBP) + (SBP)]/3
- Twice as Much of the Cardiac Cycle is Spent in Diastole, Relative to Systole
- Terms
- MAP: mean arterial blood pressure (in mm Hg)
- SBP: systolic blood pressure (in mm Hg)
- DBP: diastolic blood pressure (in mm Hg)
- Normal MAP: 85-95 mm Hg
Cardiac Output (CO)
Cardiac Output Measurement Technique
Thermodilution Cardiac Output (Utilizing a Swan-Ganz Catheter) (see Swan-Ganz Catheter)
- Thermodilution Method Allows Measurement of Cardiac Output Using the Injection of Cold Saline through a Port on the Swan-Ganz Catheter, Using a Temperature-Sensitive Thermistor on the Catheter to Measure the Rate of Clearance of the Cold Saline
- Utilizing Principles Developed by Fick in the Late 19th Century, the Rate of Clearance of Cold Saline is Proportional to the Blood Flow Rate (i.e. Cardiac Output)
- The Area Under the Thermodilution Curve is Inversely Related to the Cardiac Output (i.e. High Cardiac Output Results in Rapid Clearance of the Cold Saline, Resulting in a Small Area Under the Curve)
- Variability in Serial Thermodilution Cardiac Output Measurements
- Variability in Cardiac Output Values Obtained by Thermodilution is Approximately 10%
- Therefore, Changes in Cardiac Output Should Generally Be on the Order of 15% to Be Regared as Valid
- Variability in Cardiac Output Values Obtained by Thermodilution is Approximately 10%
- Etiology of Falsely Decreased Cardiac Output
- Tricuspid Regurgitation (TR) (see Tricuspid Regurgitation: local “recirculation” of injectate mimics slow injectate clearance
- Pulmonic Regurgitation (see Pulmonic Regurgitation): local “recirculation” of injectate mimics slow injectate clearance
- Erroneously High Cold Saline Injectate Volume
- Etiology of Falsely Increased Cardiac Output
- Intracardiac Shunt (in Either Direction) (see Intracardiac and Extracardiac Shunt): alters curve and makes cardiac output calculation less accurate
- Low Cardiac Output State: injectate can disperse into the surrounding tissue, mimicking rapid injectate clearance
- Erroneously Low Cold Saline Injectate Volume
- Early Recirculation on Thermodilution Curve
- Suggests Presence of Left-to-Right Intracardiac Shunt
- Continuous Cardiac Output Measurement
- Swan-Ganz Catheters with the Capability to Measure Cardiac Output “continuously” (Actually Averages the Cardiac Output Over a Few Minute Window) are Commercially Available
Fick Cardiac Output
- Fick Cardiac Output = Oxygen Consumption/(10 x Arterial-Venous Oxygen Difference)
- Determination of Oxygen Consumption
- Oxygen Consumption (Estimated) Can Be Obtained from a Nomogram Which Utilizes Age, Sex, Height, and Weight
- Oxygen Consumption Can Also Be Determined Using Breath Analysis
FloTrac (see FloTrac)
- Noninvasive Cardiac Output Measurement Device
- Requires Arterial Line Placement and Vigileo Monitor (see Arterial Line)
Cardiac Output Equation
- CO = SV x HR
- CO = [(LV-EF x LV-EDV) – MR] x HR
- Terms
- CO: cardiac output
- SV: stroke volume = (LV-EF x LV-EDV) – MR
- HR: heart rate
- LV-EF: left ventricular ejection fraction
- LV-EDV: left ventricular end-diastolic volume
- MR: mitral regurgitation
- Terms
Etiology of Decreased Cardiac Output
Cardiogenic Shock (Cardiac Pump Failure Due to a Cardiac Etiology) (see Cardiogenic Shock)
Arrhythmia/Conduction Disturbance
- Bradyarrhythmia
- Second Degree Atrioventricular Block-Mobitz Type II (Second Degree Heart Block-Mobitz Type II) (see Second Degree Atrioventricular Block-Mobitz Type II)
- Sinus Bradycardia (see Sinus Bradycardia)
- Sinus Node Dysfunction (see Sinus Node Dysfunction)
- Third Degree Atrioventricular Block (Third Degree Heart Block, Complete Heart Block) (see Third Degree Atrioventricular Block)
- Tachyarrythmia
- Atrial Fibrillation (see Atrial Fibrillation): particularly with rapid ventricular response
- Atrial Flutter (see Atrial Flutter): particularly with rapid ventricular response
- Supraventricular Tachycardia (SVT) (see Supraventricular Tachycardia)
- Ventricular Fibrillation (see Ventricular Fibrillation)
- Ventricular Tachycardia (VT) (see Ventricular Tachycardia)
Cardiomyopathy (see Congestive Heart Failure)
- Primary Cardiomyopathies (Predominantly Involving the Heart)
- Genetic
- Arrhythmogenic Right Ventricular Cardiomyopathy (Arrhythmogenic Right Ventricular Dysplasia) (see Arrhythmogenic Right Ventricular Cardiomyopathy)
- Conduction System Disease
- Lenegre Disease
- Sinus Node Dysfunction (see Sinus Node Dysfunction)
- Glycogen Storage Diseases
- Danon
- PRKAG2
- Hypertrophic Cardiomyopathy
- Ion Channelopathies
- Brugada Syndrome
- Catecholaminergic Polymorphic Ventricular Tachycardia
- Idiopathic Ventricular Fibrillation
- Long-QT Syndrome
- Short-QT Syndrome
- Left Ventricular Noncompaction
- Mitochondrial Myopathies
- Mixed (Predominantly Non-Genetic; Familial Disease with a Genetic Origin has been Reported in a Minority of Cases)
- Dilated Cardiomyopathy: this is a heterogeneous group of disorders characaterized by ventricular dilation and decreased myocardial contractility in the absence of abnormal loading (valvular heart disease, hypertension)
- Restrictive Cardiomyopathy (Non-Dilated and Non-Hypertrophied)
- Acquired
- Cardiomyopathy in Infants of Insulin-Dependent Diabetic Mothers
- Myocarditis (Inflammatory Cardiomyopathy) (see Myocarditis)
- Peripartum Cardiomyopathy
- Tachycardia-Induced Cardiomyopathy
- Takotsubo Cardiomyopathy (Stress Cardiomyopathy) (see Takotsubo Cardiomyopathy)
- Genetic
- Secondary Cardiomyopathies
- Cardiofacial
- Lentiginosis
- Noonan Syndrome
- Endocrine/Metabolic
- Acidosis (see Metabolic Acidosis-General)
- Acromegaly (see Acromegaly)
- Diabetes Mellitus (see Diabetes Mellitus)
- Growth Hormone Deficiency: growth hormone and insulin-like growth factor 1 and required for cardiac development
- Hyperparathyroidism (see Hyperparathyroidism)
- Hyperthyroidism (see Hyperthyroidism)
- Hypocalcemia (see Hypocalcemia)
- Hypokalemia (see Hypokalemia)
- Hypophosphatemia (see Hypophosphatemia)
- Hypothyroidism (see Hypothyroidism)
- Hypoxia (see Hypoxemia)
- Obesity (see Obesity)
- Pheochromocytoma (see Pheochromocytoma)
- Endomyocardial
- Endomyocardial Fibrosis
- Hypereosinophilic Syndrome (Löeffler’s Endocarditis????)(see Hypereosinophilic Syndrome)
- Hematologic Disease
- Sickle Cell Disease (see Sickle Cell Disease)
- Anemia (see Anemia)
- Henoch-Schonlein Purpura (see Henoch-Schonlein Purpura)
- Infectious/Inflammatory
- Hantavirus Cardiopulmonary Syndrome (see Hantavirus Cardiopulmonary Syndrome): unusually produces sepsis with a low CO and high SVR physiology
- Hantavirus Genus: Sin Nombre Virus (SNV) is the most commonly associated Hantavirus in the US
- Hemorrhagic Fever with Renal Syndrome (HFRS) (see Hemorrhagic Fever with Renal Syndrome)
- Hantavirus Genus: Hantaan Virus, Dobrova Virus, Seoul Virus (Baltimore Rat Virus)
- Sarcoidosis (see Sarcoidosis)
- Sepsis-Induced Myocardial Depression (see Sepsis)
- Hantavirus Cardiopulmonary Syndrome (see Hantavirus Cardiopulmonary Syndrome): unusually produces sepsis with a low CO and high SVR physiology
- Infiltrative (Accumulation of Abnormal Substances in Extracellular Space Between Myocytes)
- Amyloidosis (see Amyloidosis)
- Gaucher’s Disease
- Hunter’s Syndrome
- Hurler’s Syndrome
- Ischemic
- Acute Myocardial Infarction (MI) (see Coronary Artery Disease)
- Physiology: involving >40% of left ventricular myocardium or right ventricular infarction
- Myocardial Ischemia
- Stunned Myocardium (from Prolonged Ischemia)
- Cardiac Arrest (see Cardiac Arrest)
- Post-Cardiopulmonary Bypass (CPB) (see Cardiopulmonary Bypass)
- Prolonged Hypotension
- Acute Myocardial Infarction (MI) (see Coronary Artery Disease)
- Neoplasm
- Leukemia
- Multiple Myeloma (see Multiple Myeloma)
- Neuromuscular/Neurologic
- Becker Muscular Dystrophy (see Becker Muscular Dystrophy)
- Chronic Progressive External Opthmoplegia (Kearns-Savre)
- Duchenne Muscular Dystrophy (see Duchenne Muscular Dystrophy)
- Emery-Dreifuss Muscular Dystrophy
- Familial Centronuclear Myopathy
- Fascioscapulohumeral Dystrophy (Landouzy-Dejerine)
- Friedrich’s Ataxia
- Humuloperitoneal Ataxia
- Juvenile Progressive Spinal Muscular Atrophy (Kugelberg-Welander)
- Limb-Girdle Muscular Dystrophy
- Myotonia Atrophica (Steinert)
- Myotonic Dystrophy
- Neurofibromatosis (see Neurofibromatosis)
- Tuberous Sclerosis (see Tuberous Sclerosis)
- Nutritional
- Rheumatologic
- Behcet’s Disease (see Behcet’s Disease)
- Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome) (see Eosinophilic Granulomatosis with Polyangiitis)
- Granulomatosis with Polyangiitis (GPA, Wegener’s Granulomatosis) (see Granulomatosis with Polyangiitis)
- Microscopic Polyangiitis (see Microscopic Polyangiitis)
- Polyarteritis Nodosa (PAN) (see Polyarteritis Nodosa)
- Polydermatomyositis (see Polydermatomyositis)
- Rheumatoid Arthritis (RA) (see Rheumatoid Arthritis)
- Scleroderma (see Scleroderma)
- Systemic Lupus Erythematosus (SLE) (see Systemic Lupus Erythematosus)
- Storage (Accumulation of Abnormal Substances Intracellularly Within Myocytes)
- Fabry’s Disease
- Hemochromatosis (see Hemochromatosis)
- Niemann-Pick Disease
- Ochronosis
- Oxalosis (see Primary Hyperoxaluria)
- Pompe’s Disease
- Traumatic
- Cardiac Contusion (see Cardiac Contusion)
- Drug/Toxin
- 5-Fluorouracil (5-FU) (see 5-Fluorouracil)
- Amiodarone (see Amiodarone)
- Pharmacology: negative inotropy can occur in patients with preexisting left ventricular dysfunction with EF <35% (amiodarone also casuses peripheral vasodilation, which may offset some of the negative inotropy)
- Amphetamine (see Amphetamine)
- Anabolic Steroids (see xxxx)
- Antimalarials
- Chloroquine (Aralen) (see Chloroquine)
- Hydroxychloroquine (Plaquenil) (see Hydroxychloroquine)
- Antimony (see Antimony)
- Antracyclines
- Daunorubicin (Daunomycin, Cerubidine) (see Daunorubicin)
- Doxorubicin (Adriamycin) (see Doxorubicin)
- Arsenic (see Arsenic)
- β-Blocker Intoxication (see β-Adrenergic Receptor Antagonists)
- Pharmacology: negative inotropy may particularly occur in the setting of intoxication
- Calcium Channel Blocker Intoxication (see Calcium Channel Blockers)
- Pharmacology: negative inotropy may particularly occur in the setting of intoxication
- Carboxyhemoglobinemia (see Carboxyhemoglobinemia)
- Carbon Tetrachloride (see Carbon Tetrachloride)
- Catecholamines
- Clozapine (Clozaril) (see Clozapine)
- Cobalt (see Cobalt)
- Cocaine (see Cocaine)
- Cyclophosphamide (Cytoxan) (see Cyclophosphamide)
- Emetine(see Emetine)
- Ephedra (see Ephedra)
- Ethanol (see Ethanol)
- Hydrocarbon Intoxication (see Hydrocarbons)
- Interferons (see Interferons)
- Lead (see Lead)
- Lithium (see Lithium)
- Mercury (see Mercury)
- Methamphetamine (see Methamphetamine)
- Acute Methamphetamine Intoxication
- Chronic Methamphetamine Abuse
- Methylphenidate (Ritalin) (see Methylphenidate)
- Methysergide (see Methysergide)
- Mitomycin-C (see Mitomycin)
- Phenothiazines (se Phenothiazines)
- Propofol Infusion Syndrome (see Propofol)
- Taxanes (see Taxanes)
- Docetaxel (Taxotere) (see Docetaxel)
- Paclitaxel (Taxol) (see Paclitaxel)
- Trastuzumab (Herceptin) (see Trastuzumab)
- Tricyclic Antidepressants (see Tricyclic Antidepressants)
- White Phosphorus Toxicity (see White White Phosphorus)
- Widow Spider Bite (see Widow Spider Bite): cardiomyopathy occurs rarely
- Zidovudine (Retrovir) (see Zidovudine)
- Other
- Radiation Therapy (see Radiation Therapy)
- Stiff Left Atrial Syndrome Following Left Atrial Catheter Ablation (see Stiff Left Atrial Syndrome)
- Cardiofacial
Increased Afterload
- Aortic Coarctation (see Aortic Coarctation)
- Epidemiology
- Congenital: most cases
- Acquired: few cases
- Physiology
- Narrowing of Descending Aorta (Typically at the Insertion of the Ductus Arteriosus Distal to the Left Subclavian Artery), Resulting in Left Ventricular Pressure Overload
- Epidemiology
- Hypertrophic Obstructive Cardiomyopathy (HOCM) (see Hypertrophic Cardiomyopathy)
- Malignant Hypertension (see Hypertension)
- Physiology
- Left Ventricular Pressure Overload
- Physiology
- Severe Aortic Stenosis (see Aortic Stenosis)
Intracardiac Shunt
- Atrial Septal Defect (ASD) (see Atrial Septal Defect)
- Physiology
- Left-to-Right or Right-to-Left Intracardiac Shunt
- Physiology
- Ruptured Sinus of Valsalva Aneurysm (see Sinus of Valsalva Aneurysm)
- Physiology
- Ruptured Sinus of Valsalva Aneurysm May Produce Aortic Insufficiency, Tricuspid Regurgitation, Left-to-Right or Right-to-Left Shunt, and/or Sudden Cardiac Death
- Physiology
- Ventricular Septal Defect (VSD) (see Ventricular Septal Defect)
- Physiology
- Left-to-Right or Right-to-Left Intracardiac Shunt
- Physiology
- Ventricular Septal Rupture (see Ventricular Septal Rupture)
- Physiology
- Left-to-Right or Right-to-Left Intracardiac Shunt
- Physiology
Valvular Heart Disease/Cardiac Mechanical Disturbance/Intracardiac Shunt
- Aortic Insufficiency (AI) (see Aortic Insufficiency)
- Epidemiology
- Aortic Insufficiency May Be Acute in the Setting of Ascending Aortic Dissection
- Physiology
- Portion of Left Ventricular Stroke Volume Regurgitates Back from the Aorta into the Left Ventricle, Resulting in Increased Left Ventricular End-Diastolic Volume and Increased Left Ventricular Wall Stress
- Epidemiology
- Aortic Stenosis (AS) (see Aortic Stenosis)
- Physiology
- Increased Left Ventricular Afterload
- Physiology
- Atrial Myxoma (see Atrial Myxoma)
- Physiology
- Symptomatic Left Atrial Tumors Typically Result in Obstruction to Blood Flow, Mitral Regurgitation, and/or Systemic Embolization
- Physiology
- Atrial Septal Defect (ASD) (see Atrial Septal Defect)
- Physiology
- Left-to-Right or Right-to-Left Intracardiac Shunt
- Physiology
- Atrial Thrombus (see Intracardiac Thrombus)
- Physiology
- May Result in Systemic Embolization (or Less Commonly, Obstruction to Blood Flow)
- Physiology
- Constrictive Pericarditis (see Constrictive Pericarditis)
- Physiology
- Early Diastolic Ventricular Filling is More Rapid Than Normal
- However, Starting in Mid-Diastole, Inelastic Pericardium Results in Compression, Impairing Further Ventricular Filling and Compromising Stroke Volume
- Physiology
- Hypertrophic Obstructive Cardiomyopathy (HOCM) (see Hypertrophic Cardiomyopathy)
- Physiology
- Left Ventricular Outflow Tract Obstruction
- Physiology
- Left Ventricular Aneurysm (see Left Ventricular Aneurysm)
- Physiology
- Bulging of Left Ventricular Wall, Resulting in Decreased Stroke Volume
- In Rare Cases Where Left Ventricular Aneurysm Rupture Occurs, Tamponade May Occur
- Physiology
- Left Ventricular Pseudoaneurysm (see Left Ventricular Pseudoaneurysm)
- Physiology
- Cardiac Rupture is Contained by Adherent Pericardium or Scar Tissue (Pseudoaneurysm Contains No Endocardium or Myocardium), Resulting in Decreased Stroke Volume
- In Cases Where Left Ventricular Pseudoaneurysm Rupture Occurs, Tamponade May Occur
- Physiology
- Left Ventricular Thrombus (see Left Ventricular Thrombus)
- Physiology
- May Result in Systemic Embolization (or Less Commonly, Obstruction to Blood Flow)
- Physiology
- Mitral Regurgitation (MR) (see Mitral Regurgitation)
- Epidemiology
- Mitral Regurgitation May Be Acute in the Setting of Myocardial Infarction-Associated Papillary Muscle Dysfunction/Rupture or Chordae Tendineae Rupture
- Physiology
- Decreased Effective Forward Flow
- Epidemiology
- Mitral Stenosis (see Mitral Stenosis)
- Physiology
- Impaired Left Ventricular Filling
- Physiology
- Pulmonic Stenosis (see Pulmonic Stenosis)
- Physiology
- Right Ventricular Pressure Overload
- Physiology
- Restrictive Cardiomyopathy (see Congestive Heart Failure)
- Physiology
- Diastolic Dysfunction (Restricted Filling)
- Physiology
- Ruptured Sinus of Valsalva Aneurysm (see Sinus of Valsalva Aneurysm)
- Physiology
- May Produce Aortic Insufficiency, Tricuspid Regurgitation, Left-to-Right or Right-to-Left Shunt, and/or Sudden Cardiac Death
- Physiology
- Tamponade (see Tamponade)
- Physiology
- Diastolic Dysfunction
- Physiology
- Tricuspid Regurgitation (TR) (see Tricuspid Regurgitation)
- Physiology
- Right Ventricular Pressure/Volume Overload, Resulting in Right Ventricular Systolic Dysfunction
- Physiology
- Tricuspid Stenosis (see Tricuspid Stenosis)
- Physiology
- Impaired Right Ventricular Filling
- Physiology
- Ventricular Septal Defect (VSD) (see Ventricular Septal Defect)
- Physiology
- Left-to-Right or Right-to-Left Intracardiac Shunt
- Physiology
- Ventricular Septal Rupture (see Ventricular Septal Rupture)
- Physiology
- Left-to-Right or Right-to-Left Intracardiac Shunt
- Physiology
Obstructive Shock (Cardiac Pump Failure Due to an Extracardiac Etiology)
Mechanical
- Aortocaval Compression (Due to Positioning or Surgical Retraction)
- Physiology
- Compression of Aorta, Resulting in Increased Afterload
- Compression of Inferior Vena Cava, Resulting in Impaired Right-Sided Venous Return
- Physiology
- Increased Intrathoracic Pressure (with Impaired Right-Sided Venous Return)
- Abdominal Compartment Syndrome (see Abdominal Compartment Syndrome)
- Physiology
- Increased Intraabdominal Pressure, Resulting in Transmission with Intrathoracic Pressure, Culminating in Impaired Right-Sided Venous Return
- Increased Intraabdominal Pressure, Resulting in Impaired Right-Sided Venous Return
- Increased Intraabdominal Pressure, Resulting in Increased Afterload
- Physiology
- Dynamic Hyperinflation Associated with High Positive End-Expiratory Pressure (PEEP)/Auto-PEEP (see PEEP + Auto-PEEP)
- Physiology
- Increased Intrathoracic Pressure, Resulting in Impaired Right-Sided Venous Return
- Physiology
- Hemothorax (see Pleural Effusion-Hemothorax)
- Physiology
- Increased Intrathoracic Pressure, Resulting in Impaired Right-Sided Venous Return
- Physiology
- Herniation of Abdominal Viscera Into Thorax
- Physiology
- Due to Movement of Abdominal Visceral Contents into the Thoracic Cavity, there is Increased Intrathoracic Pressure, Resulting in Impaired Right-Sided Venous Return
- Physiology
- Positive-Pressure Ventilation with High Airway Pressures (see Acute Respiratory Distress Syndrome)
- Physiology
- Increased Intrathoracic Pressure, Resulting in Impaired Right-Sided Venous Return
- Physiology
- Tension Pneumothorax (see Pneumothorax
- Physiology
- Increased Intrathoracic Pressure, Resulting in Impaired Right-Sided Venous Return
- Physiology
- Abdominal Compartment Syndrome (see Abdominal Compartment Syndrome)
Pulmonary Vascular
- Acute or Severe Pulmonary Hypertension (see Pulmonary Hypertension)
- General Comments: typically causes right-sided heart failure
- Acute Pulmonary Embolism (PE) (see Acute Pulmonary Embolism)
- Chronic Thromboembolic Pulmonary Hypertension (CTEPH) (see Chronic Thromboembolic Pulmonary Hypertension)
- Idiopathic Pulmonary Arterial Hypertension (IPAH) (see Idiopathic Pulmonary Arterial Hypertension)
- Other Causes of Severe Pumonary Hypertension
- Venous Air Embolism (see Air Embolism)
Etiology of Increased Cardiac Output (J Am Coll Cardiol, 2016) [MEDLINE])
General Comments
- Many of the Following Conditions are Classified as Etiologies of “High Output Heart Failure”
- However, this Term is a Misnomer, Since the Heart is Generally Normal (Capable of Generating a High Cardiac Output) and the Underlying Pathophysiology is Decreased Systemic Vascular Resistance, Resulting in Activation of Neurohormones Which Increase Renal Salt and Water Retention (and May Result in Hypotension)
- Treatment with Vasodilators (Typically Used in Congestive Heart Failure) May Exacerbate the Heart Failure in These Conditions
Conditions with Predominant Peripheral Vascular Effects
- Carcinoid Syndrome (see Carcinoid Syndrome)
- Physiology
- Peripheral Vasodilation with Decreased Systemic Vascular Resistance
- Clinical
- Physiology
- Cirrhosis/Liver Disease (see Cirrhosis)
- Physiology
- Progressive Systemic Vasodilation (Especially Splanchnic) with Development of Intrahepatic/Mesenteric Arteriovenous Shunts
- Intrapulmonary Arteriovenous Shunts (i.e. Hepatopulmonary Syndrome) May Also Occur (Echocardiography, 2006) [MEDLINE] (see Hepatopulmonary Syndrome)
- Clinical
- Characteristically Produces a High Cardiac Output/Low Systemic Vascular Resistance State
- High Output Heart Failure May Occur
- Of All of the High Output Heart Failure Conditions, Cirrhosis Generally Produces the Lowest Arterial-Venous Oxygen Difference and the Lowest Systemic Vascular Resistance
- Physiology
- Erythroderma (of Any Etiology) (see Erythroderma)
- Etiology
- Drug Hypersensitivity Reaction
- Psoriasis (see Psoriasis)
- Physiology
- Significant Cutaneous Vasodilation and Increased Blood Flow to the Skin, Resulting in Shunting of Blood Flow Through the Skin
- Etiology
- Morbid Obesity (see Obesity)
- Physiology
- Peripheral Vasodilation with Decreased Systemic Vascular Resistance (of Unclear Etiology)
- Leptin-Induced Expansion of Plasma Volume and Eccentric Ventricular Dilation/Hypertrophy (Circulation, 2018) [MEDLINE]
- Obesity-Associated Hypertension (with Pressure Overload) Likely Exacerbates the Effect of Obesity on Cardiac Output (Physiol Rep, 2015) [MEDLINE]
- Clinical
- High Cardiac Output (Although Cardiac Output is Normal When Adjusted for Body Weight)
- Physiology
- Systemic Arteriovenous Fistula (AVF) (see Systemic Arteriovenous Fistula)
- Etiology
- Aortocaval Fistula (Due to Spontaneous Rupture of Aortic Aneurysm)
- Congenital Arteriovenous Fistula
- Hemangioma (see Hemangioma)
- Hereditary Hemorrhagic Telangiectasia (HHT) (see Hereditary Hemorrhagic Telangiectasia)
- Highly Vascular Condition/Tumor
- Giant Placental Chorioangioma
- Renal Cell Carcinoma (see Renal Cancer)
- Wilms’ Tumor (see Wilms’ Tumor)
- Iatrogenic
- Femoral/Radial/Ulnar Arteriovenous Fistula (Due to Arterial Access for Cardiac Catheterization for Coronary Angiogram)
- Iliac Arteriovenous Fistula (Due to Spinal/Abdominal Surgery)
- Renal Arteriovenous Fistula (Due to Renal Biopsy)
- Surgically-Constructed Arteriovenous Access for Hemodialysis
- Transjugular Intrahepatic Portosystemic Shunt (TIPS) (see Transjugular Intrahepatic Portosystemic Shunt)
- Multiple Myeloma (see Multiple Myeloma): due to multiple minute arteriovenous fistulas in bony lesions
- Paget Disease of the Bone (Osteitis Deformans) (see Paget Disease of Bone): due to multiple minute arteriovenous fistulas in bony lesions
- Polyostotic Fibrous Dysplasia (McCune-Albright Syndrome): due to multiple minute arteriovenous fistulas in bony lesions
- Trauma
- Aortocaval Fistula
- Bullet/Knife Wound (Particularly in the Thigh)
- Physiology
- High Pressure Arterial Blood is Shunted into a Low Pressure Vein, Shunting Past the Tissue Capillary Bed (and Decreasing the Systemic Vascular Resistance)
- Subsequently, there is a Compensatory Increase in Stroke Volume, Cardiac Output, and Total Plasma Volume to Maintain Capillary Perfusion
- High Pressure Arterial Blood is Shunted into a Low Pressure Vein, Shunting Past the Tissue Capillary Bed (and Decreasing the Systemic Vascular Resistance)
- Clinical
- High Output Heart Failure May Occur
- Worsening of Pulmonary Hypertension (see Pulmonary Hypertension)
- Etiology
Conditions with Predominant Metabolic Effects
- Hyperthyroidism (see Hyperthyroidism)
- Physiology
- Enhanced Sympathoadrenal Activation
- Direct Myocardial Chronotropic and Inotropic Effects
- Hyperthyroidism-Associated β-Adrenergic Stimulation Has Been Proposed to Have a Cardiotoxic Effect (Heart, 2007) [MEDLINE]
- Clinical
- Widened Pulse Pressure (see Widened Pulse Pressure)
- High Cardiac Output/Low Systemic Vascular Resistance State May Occur (with High Output Heart Failure) (NEJM, 2001) [MEDLINE]
- Sympatholytic Agents (β-Blockers) Can Partially Decrease Heart Rate and Cardiac Output, as Well as Partially Improve Pulse Pressure
- Hyperthyroidism-Associated Hyperdynamic Right Ventricular Function (Which is Reversible with Treatment) Has Also Been Reported (Heart Lung Circ, 2017) [MEDLINE]
- Hyperthyroidism-Associated Decreased Cardiac Output May Alternately Occur (Due to Tachycardia-Mediated Cardiomyopathy or Associated Cardiac Disease) (Heart, 2007) [MEDLINE]
- Hyperthyroidism-Associated Reversible Right Ventricular Failure with Pulmonary Hypertension Has Also Been Reported (Am J Med Sci, 2018) [MEDLINE]
- Physiology
- Myeloproliferative Disorders with Extramedullary Hematopoiesis
- Etiology
- Leukemia
- Myelofibrosis (see Myelofibrosis-Myelophthisis)
- Polycythemia Vera (see Polycythemia Vera)
- Physiology
- Increased Metabolic State with Increased Oxygen Consumption and Decreased Systemic Vascular Resistance
- Etiology
Conditions with Myocardial and Peripheral Vascular Effects
- Acromegaly (see Acromegaly)
- Epidemiology
- Heart Failure May Be Present in Newly-Diagnosed Acromegaly
- Physiology
- Growth Hormone is Involved in the Maintenance of Normal Cardiac Function
- Epidemiology
- Anagrelide (Agrylin, Xagrid) (see Anagrelide)
- Epidemiology
- Used in the Treatment of Essential Thrombocythemia (see Essential Thrombocythemia)
- Pharmacology
- Phosphodiesterase III Inhibition, Resulting in Positive Inotropic/Chronotropic Effects and Vasodilation
- Epidemiology
- Dobutamine (Dobutrex) (see Dobutamine)
- Pharmacology
- Myocardial β1-Adrenergic Receptor Agonist (Chronotropic/Inotropic Effects) and Vascular β2-Adrenergic/α1-Adrenergic Receptor Agonist (if Vascular β2-Adrenergic Effects Exceed α1-Adrenergic Receptor Agonist Effects, Some Peripheral Vasodilation May Occur)
- Pharmacology
- Milrinone (see Milrinone)
- Pharmacology
- Phosphodiesterase Type 3 Inhibitor (Which Inhibits cAMP Degradation), Resulting in Increased Myocardial Contractility and Vasodilation
- Pharmacology
- Mitochondrial Disease
- Physiology
- Altered Oxidative Metabolism
- Clinical
- Cardiomyopathy
- Decreased Systemic Vascular Resistance (SVR)
- Lactic Acidosis (see Lactic Acidosis)
- Physiology
- Sepsis (see Sepsis)
- Physiology
- Due to Inflammatory Response (Involving TNF-α, IL-1β, IL-6, etc)
- Clinical
- Characteristically Produces a High Cardiac Output/Low Systemic Vascular Resistance State (Although Sepsis-Induced Myocardial Dysfunction May Alternately Occur)
- High Output Heart Failure May Occur
- Physiology
- Thiamine (Vitamin B1) Deficiency (Beriberi) (see Thiamine)
- Physiology
- Vasodilation May Occur Due to Direct Depression of Vasomotor Function (Am J Med, 1966) [MEDLINE]
- Thiamine Deficiency Impairs Lactate and Pyruvate Utilization by the Myocardium (These Substrates are Important for Oxidation and Energy Production in the Myocardium)
- Thiamine Deficiency Impairs Hexose Monophosphate Shunt Function, Impairing Tissue Oxygenation
- Clinical
- Physiology
Other
- Anemia (Chronic, Severe) (see Anemia)
- Epidemiology
- May Occur in Patients with Beta-Thalassemia Intermedia (see Thalassemias)
- Physiology
- Endothelial Dysfunction, Resulting in Peripheral Vasodilation
- Decreased Serum Viscosity, Resulting in Decreased Left Ventricular Afterload
- Loss of Hemoglobin is Partly Compensated for by an Increase in Cardiac Output and Widening of the Arteriovenous O2 Difference
- Severe Anemia Can Result in Left Ventricular Volume Overload and Increased Stroke Volume
- Clinical
- Heart Failure Generally Occurs in the Absence of Underlying Heart Disease Only with Severe Anemia (Hemoglobin <5 g/dL)
- Epidemiology
- Anxiety or Physical/Emotional Stress (see Anxiety)
- Physiology
- Stress Induces Catecholamine Release, Resulting in Increased Cardiac Output and Variable effects on Systemic Vascular Resistance
- Physiology
- Chronic Pulmonary Disease
- Epidemiology
- Chronic Pulmonary Disease Associated with Hypoxemia and/or Hypercapnia is Associated with High Output Heart Failure
- Physiology
- Decreased Systemic Vascular Resistance (SVR)
- Impaired Renal Blood Flow
- Salt and Water Retention
- Epidemiology
- Exercise
- Physiology
- During Exercise, Cardiac Output Increases and Systemic Vascular Resistance Decreases
- Physiology
- Fever (see Fever)
- Physiology
- Fever Increases Metabolic Demand and Produces Vasodilation (Especially in the Skin)
- Physiology
- Hot Climate
- Physiology
- Hot (and Especially Humid) Environment Increases Cardiac Output (Similar to Fever)
- Physiology
- Pregnancy (see Pregnancy)
- Physiology
- Decreased Systemic Vascular Resistance (SVR)
- Increased Blood Volume
- Increased Maternal Heart Rate (by 15-20 bpm)
- Increased Metabolic Demand
- Increased Resting Cardiac Output (to 30-50% Above Baseline)
- Placental Blood Flow (Which May Function an Arteriovenous Shunt)
- Physiology
Systemic Vascular Resistance (SVR)
Calculation of Systemic Vascular Resistance (SVR) Using Pressures Measured from Swan-Ganz Catheter (see Swan-Ganz Catheter)
- Calculation Technique
- Systemic Vascular Resistance (SVR) is Calculated from the Mean Arterial Pressure (MAP), Central Venous Pressure (CVP), and Cardiac Output (CO)
- Unlike, Systemic Vascular Resistance, All Three of These Latter Parameters are Measured
- Systemic Vascular Resistance (SVR) is Calculated from the Mean Arterial Pressure (MAP), Central Venous Pressure (CVP), and Cardiac Output (CO)
- Equation: SVR = [(MAP-CVP)/CO] x 80
- Normal SVR Values (using dynes-sec/cm5): 770-1500 dynes-sec/cm5
- Note: SVR normal values can alternatively be expressed as 9–20 Woods units (9-20 mm Hg-min/L) -> to convert from Woods units to dynes-sec/cm5, multiply by 80
Etiology of Decreased Systemic Vascular Resistance (Distributive Shock)
Anaphylaxis/Anaphylactic Shock
- Anaphylaxis (see Anaphylaxis)
- Physiology
- Peripheral Vasodilation (Due to Histamine and Other Vasoactive Substances)
- Physiology
Infection
- Anaplasmosis Sepsis-Like or Toxic Shock-Like Syndrome (see Anaplasmosis)
- Ehrlichiosis Sepsis-Like or Toxic Shock-Like Syndrome (see Ehrlichiosis)
- Sepsis/Septic Shock (see Sepsis)
- Epidemiology
- Sepsis is the Most Common Etiology of Distributive Sshock
- Physiology
- Third-Spacing of Fluids (with Decreased Intravascular Volume) and Peripheral Vasodilation
- Epidemiology
- Toxic Shock Syndrome (TSS)
- Types
- Staphylococcal Toxic Shock Syndrome (see Staphylococcal Toxic Shock Syndrome)
- Streptococcal Toxic Shock Syndrome (see Streptococcal Toxic Shock Syndrome)
- Physiology
- Peripheral Vasodilation
- Types
Systemic Inflammatory Response Syndrome (SIRS)
- Acute Pancreatitis (see Acute Pancreatitis)
- Physiology
- Third-Spacing of Fluids (with Decreased Intravascular Volume) and Peripheral Vasodilation
- Physiology
- Air Embolism (see Air Embolism)
- Physiology
- Arterial Air Embolism
- Air Bubbles Occlude the Arterial Microcirculation, Resulting in Ischemia-Induced Endothelial Damage and Release of Inflammatory Mediators, Culminating in End-Organ Injury
- Venous Air Embolism
- Air Bubbles in the Pulmonary Microcirculation Result in Local Endothelial Damage, Culminating in Bronchospasm/Acute Lung Injury
- Arterial Air Embolism
- Physiology
- Amniotic Fluid Embolism (see Amniotic Fluid Embolism)
- Burns (see Burns)
- Crush Injury
- Fat Embolism (see Fat Embolism)
- Idiopathic Systemic Capillary Leak Syndrome (see Idiopathic Systemic Capillary Leak Syndrome)
- Post-Cardiac Arrest with Return of Spontaneous Circulation (see Cardiac Arrest)
- Trauma (see Trauma-General)
Endocrine/Nutritional Deficiency-Associated Hypotension
- Adrenal Insufficiency (see Adrenal Insufficiency)
- Physiology
- Peripheral Vasodilation
- Physiology
- Hyperthyroidism (see Hyperthyroidism)
- Physiology
- XXXX
- Physiology
- Hypocalcemia (see Hypocalcemia)
- Epidemiology
- Cases of Hypocalcemia-Associated Hypotension Have Been Extensively Reported (Am J Kidney Dis, 1994) [MEDLINE] (Am J Kidney Dis, 2015) [MEDLINE] (Hemodial Int, 2016) [MEDLINE]
- Hypocalcemia-Associated Hypotension is Most Commonly Seen When it is Rapidly Induced by Ethylenediaminetetraacetic Acid (EDTA), Transfusion of Citrated Blood, Products, or with the Use of Low Calcium Dialysate in Patients Undergoing Dialysis
- Epidemiology
- Hypothyroidism/Myxedema (see Hypothyroidism)
- Physiology
- Peripheral Vasodilation
- Physiology
- Pheochromocytoma (see Pheochromocytoma)
- Epidemiology
- Occurs in Some Cases
- Clinical Patterns
- Episodic Hypotension: in rare cases where the tumor secretes only epinephrine
- Pattern of Rapid Cyclic Fluctuation Between Hypertension and Hypotension (Cycling Every 7-15 min): unclear mechanism
- Orthostatic Hypotension: due predominantly to decreased plasma volume
- Epidemiology
- Thiamine Deficiency (Beriberi) (see Thiamine)
- Physiology
- Peripheral Vasodilation
- Physiology
Hematologic Disease-Associated Hypotension
- Acute Graft vs Host Disease (see Graft vs Host Disease)
- Acute Hemolytic Transfusion Reaction (see Acute Hemolytic Transfusion Reaction)
- Anemia (Severe, Long-Standing) (see Anemia)
Neurogenic Shock (see Neurogenic Shock)
- Acute Spinal Cord Injury (SCI) (see Acute Spinal Cord Injury)
- Physiology
- Interruption of Autonomic Pathways, Resulting in Decreased Systemic Vascular Resistance and Altered Vagal Tone: probably the predominant mechanism
- Myocardial Depression: may also play a role
- Acute Blood Loss: may also play a role in some cases
- Physiology
- Brain Herniation (Due to Foramen Magnum Herniation) (see Increased Intracranial Pressure)
- Physiology
- Compression of Brainstem and/or Upper Cervical Spinal Cord
- Physiology
- Chronic Spinal Cord Injury (SCI) (see Acute Spinal Cord Injury)
- Clinical
- Autonomic Dysreflexia (see Autonomic Dysreflexia)
- Clinical
- Guillain-Barre Syndrome (GBS) (see Guillain-Barre Syndrome)
- Epidemiology
- Autonomic Dysfunction is Common in GBS (Occurs in Approximately 66% of Cases)
- Clinical
- Arrhythmias
- Blood Pressure Fluctuations
- Bradycardia/Tachycardia
- Gastrointestinal Dysfunction
- Epidemiology
- Multiple Sclerosis (see Multiple Sclerosis)
- Epidemiology
- Autonomic Dysfunction Can Occur
- Clinical
- Arrhythmias
- Bladder Dysfunction (see xxxx)
- Orthostatic Hypotension (see Orthostatic Hypotension)
- Diaphoresis (see Diaphoresis)
- Gastrointestinal Dysfunction
- Epidemiology
- Neuraxial (Spinal) Anesthesia (see Spinal Anesthesia)
- Physiology
- XXXX
- Physiology
- Transverse Myelitis (see Transverse Myelitis)
- Physiology
- XXXX
- Physiology
- Traumatic Brain Injury (TBI) (see Traumatic Brain Injury)
- Physiology
- XXXX
- Physiology
Drug/Toxin-Associated Hypotension
- Abacavir-Hypersensitivity Reaction (see Abacavir)
- Pharmacology: peripheral vasodilation
- Alcohol Intoxications
- Ethanol (see Ethanol)
- Pharmacology: peripheral vasodilation
- Ethylene Glycol Intoxication (see Ethylene Glycol)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Isopropanol Intoxication (see Isopropanol)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Methanol Intoxication (see Methanol)
- Pharmacology: peripheral vasodilation
- Ethanol (see Ethanol)
- Amiodarone (Cordarone) (see Amiodarone)
- Pharmacology
- Peripheral Vasodilation
- Negative Inotropy Can Also Occur in Patients with Preexisting Left Ventricular Dysfunction with EF <35%)
- Pharmacology
- Atypical Antipsychotics (see Antipsychotic Agents)
- Olanzapine (Zyprexa) (see Olanzapine)
- Quetiapine (Seroquel) (see Quetiapine)
- Risperidone (Risperdal) (see Risperidone)
- Benzodiazepines (see Benzodiazepines)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Capsaicin (see Capsaicin)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Cholinergic Intoxication (see Cholinergic Intoxication)
- Carbamate Intoxication (see Carbamates)
- Organophosphate Intoxication (see Organophosphates)
- Cigua Toxin Poisoning (see Cigua Toxin Poisoning)
- Physiology
- Dysfunction of Calcium and Sodium channels, Resulting in Peripheral Vasodilation
- Physiology
- Cyanide Intoxication (see Cyanide)
- Pharmacology
- Mitochondrial Dysfunction
- Clinical: hypotension occurs late in the course
- Pharmacology
- Cytokine Release Syndrome (see Cytokine Release Syndrome)
- Associated Agents
- Alemtuzumab (Campath, MabCampath, Campath-1H, Lemtrada) (see Alemtuzumab): anti-CD52 monoclonal antibody
- Anti-Thymocyte Globulin (ATG) (see Antithymocyte Globulin)
- Basiliximab (Simulect) (see Basiliximab)
- Bi-Specific Antibodies in Treatment of Leukemia
- Chimeric Antigen Receptor T-Cells (CAR-T) (see Chimeric Antigen Receptor T-Cells)
- Haploidentical Mononuclear Cells in Treatment of Refractory Leukemia
- Lenalidomide (Revlimid) (see Lenalidomide)
- Muromonab-CD3 (Orthoclone OKT3) (see Muromonab-CD3): anti-CD3 monoclonal antibody
- Oxaliplatin (Eloxatin, Oxaliplatin Medac) (see Oxaliplatin)
- Rituximab (Rituxan) (see Rituximab): chimeric monoclonal anti-CD20 antibody
- Tisagenlecleucel (Kymriah) (see Tisagenlecleucel): CAR-T (CD19-directed T-cell medication) therapy
- Pharmacology
- Peripheral Vasodilation
- Associated Agents
- Defibrotide (Defitelio) (see Defibrotide)
- Dexmedetomidine (Precedex) (see Dexmedetomidine)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Differentiation Syndrome (Retinoic Acid Syndrome) (see Tretinoin)
- Epidemiology
- Occurs During Treatment of Acute Promyelocytic Leukemia with Tretinoin (see Acute Promyelocytic Leukemia)
- Pharmacology
- Peripheral Vasodilation
- Epidemiology
- Dobutamine (Dobutrex) (see Dobutamine)
- Pharmacology
- Myocardial β1-Adrenergic Receptor Agonist (Chronotropic/Inotropic Effects) and Vascular β2-Adrenergic/α1-Adrenergic Receptor Agonist (if Vascular β2-Adrenergic Effects exceed α1-Adrenergic Receptor Agonist Effects, Some Peripheral Vasodilation May Occur)
- Pharmacology
- Eltrombopag (Promacta, Revolade)
- Pharmacology
- XXXXX
- Pharmacology
- Endothelin Receptor Antagonists (ERA’s) (see Endothelin Receptor Antagonists)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Envenomations
- Types
- Scorpion Sting (see Scorpion Sting)
- Rattlesnake Bit (see Rattlesnake Bite)
- Widow Spider Bite (see Widow Spider Bite)
- Epidemiology: hypertension is more characteristically seen in widow spider bites, hypotension occurs rarely
- Types
- Estrogen (see Estrogen)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Glyphosate Ingestion (see Glyphosate)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Hemoglobinopathies
- Carboxyhemoglobinemia (see Carboxyhemoglobinemia)
- Pharmacology
- Mitochondrial Dysfunction
- Pharmacology
- Methemoglobinemia (see Methemoglobinemia)
- Physiology
- Peripheral Vasodilation
- Physiology
- Carboxyhemoglobinemia (see Carboxyhemoglobinemia)
- Hexoprenaline (Gynipral) (see Hexoprenaline)
- Pharmacology
- β2-Adrenergic Receptor Agonist
- Pharmacology
- Hydrogen Sulfide Gas Inhalation (see Hydrogen Sulfide Gas)
- Intravenous Immunoglobulin (IVIG) (see Intravenous Immunoglobulin)
- L-Arginine (see L-Arginine)
- Pharmacology
- Nitric Oxide Induction, Resulting in Peripheral Vasodilation
- Pharmacology
- Magnesium Sulfate (see Magnesium Sulfate)
- Epidemiology
- Hypotension May Occur with Rapid Infusion
- Epidemiology
- Metal Intoxications
- N-Acetylcysteine (Mucomyst, Acetadote, Fluimucil, Parvolex) (see N-Acetylcysteine)
- Epidemiology
- Associated with Oral Administration
- Pharmacology
- Peripheral Vasodilation
- Epidemiology
- Nerium Oleander Intoxication (see Nerium Oleander)
- Neuroleptic Malignant Syndrome (NMS) (see Neuroleptic Malignant Syndrome)
- Physiology
- Autonomic Instability
- Physiology
- Nitrites and Nitrates (see Nitrites and Nitrates)
- Pharmacology
- Nitric Oxide Induction, Resulting in Peripheral Vasodilation
- Pharmacology
- Ocrelizumab (Ocrevus) (see Ocrelizumab)
- Epidemiology
- Hypotension May Occur as a Component of Infusion Reaction
- Epidemiology
- Opiates (see Opiates)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Papaverine (see Papaverine)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Phenytoin (Dilantin)Fosphenytoin (Cerebyx) (see Fosphenytoin and (see Phenytoin)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Phosphodiesterase Type 5 (PDE5) Inhibitors (see Phosphodiesterase Type 5 Inhibitors)
- Pharmacology
- Inhibition of Phosphodiesterase 5/PDE5 (the Enzyme Which Degrades cGMP), Resulting in Enhanced NO-Mediated Smooth Muscle Relaxation and Therefore, Peripheral Vasodilation
- Pharmacology
- Propofol (Diprivan) (see Propofol)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Prostaglandins with Vasodilatory Properties
- Agents
- Epoprostenol (PGI2, Prostacyclin, Flolan, Veletri) (see Epoprostenol)
- Iloprost (Ilomedin, Ventavis) (see Iloprost)
- Prostaglandin E1 (Alprostadil) (see Prostaglandin E1)
- Pharmacology
- Peripheral Vasodilation
- Agents
- Protamine (see Protamine)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Rasburicase (Elitek) (see Rasburicase)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Ruxolitinib (Jakafi) Withdrawal Syndrome (see Ruxolitinib)
- Epidemiology
- Ruxolitinib Withdrawal Syndrome Occurs 1 Day-3 wks After Drug Withdrawal
- Epidemiology
- Salicylate Intoxication (see Acetylsalicylic Acid)
- Pharmacology
- Peripheral Vasodilation
- Clinical
- Pseudosepsis with Fever, Tachypnea, Metabolic Acidosis, and Hypotension
- Pharmacology
- Scombroid (see Scombroid)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Serotonin Syndrome (see Serotonin Syndrome)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Sevelamer (Renagel, Renvela) (see Sevelamer)
- Tetrahydrocannabinol (THC) (see Tetrahydrocannabinol)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Tetrodotoxin
- Epidemiology
- Associated with Ingestion of Tetrodotoxin-Contaminated Pufferfish
- Physiology
- Tetrodotoxin Inhibits Sodium Channels on Vascular Smooth Muscle
- Epidemiology
- Theobromine (see Theobromine)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Thrombolytics (see Thrombolytics
- Transfusion-Associated Acute Lung Injury (TRALI) (see Transfusion-Associated Acute Lung Injury)
- Tricyclic Antidepressant Intoxication (see Tricyclic Antidepressants)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Vancomycin-Associated Red Man Syndrome (see Vancomycin)
- Pharmacology
- Peripheral Vasodilation
- Pharmacology
- Vasodilator Antihypertensives
- Agents
- α-Adrenergic Receptor Antagonists (see α-Adrenergic Receptor Antagonists)
- Pharmacology: α2-adrenergic receptor antagonism, resulting peripheral vasodilation
- α-Methyldopa (Aldomet, Aldoril, Dopamet, Dopegyt) (see α-Methyldopa)
- Pharmacology: α2-adrenergic receptor agonist, resulting in peripheral vasodilation
- Angiotensin Converting Enzyme (ACE) Inhibitors (see Angiotensin Converting Enzyme (ACE) Inhibitors)
- Pharmacology: angiotensin converting enzyme inhibition, resulting in peripheral vasodilation
- Angiotensin II Receptor Blockers (ARB) (see Angiotensin II Receptor Blockers)
- Pharmacology: angiotensin II receptor inhibition, resulting in peripheral vasodilation
- β-Adrenergic Receptor Antagonists (β-Blockers) (see β-Adrenergic Receptor Antagonists)
- Pharmacology: β-adrenergic receptor antagonism, resulting in decreased cardiac output and peripheral vasodilation
- Calcium Channel Blockers (see Calcium Channel Blockers)
- Pharmacology: calcium channel antagonism, resulting in peripheral vasodilation (and additionally decreased cardiac output with some of the agents)
- Clonidine (Catapres, Kapvay, Nexiclon) (see Clonidine)
- Pharmacology: α2-adrenergic receptor agonism, resulting in peripheral vasodilation
- Hydralazine (see Hydralazine)
- Pharmacology: peripheral vasodilation
- Minoxidil (see Minoxidil)
- Pharmacology: direct relaxation of arteriolar smooth muscle (possibly mediated by cAMP), resulting in peripheral vasodilation
- α-Adrenergic Receptor Antagonists (see α-Adrenergic Receptor Antagonists)
- Agents
Other
- Acidemia (see Metabolic Acidosis-Elevated Anion Gap and Metabolic Acidosis-Normal Anion Gap)
- Physiology
- Acidemia-Associated Arterial Vasodilation, Venoconstriction, and Blunted Response to Catecholamines
- Physiology
- Cirrhosis/End-Stage Liver Disease (see Cirrhosis)
- Physiology
- Liver Disease Characteristically Produces a High Cardiac Output (CO)/Low Systemic Vascular Resistance (SVR) State
- Physiology
- Hepatic Sinusoidal Obstruction Syndrome (Hepatic Veno-Occlusive Disease (see Hepatic Sinusoidal Obstruction Syndrome)
- Epidemiology
- Hepatic Sinusoidal Obstruction Syndrome May Be Associated with a Sepsis-Like Syndrome with Hypotension
- Epidemiology
- Hypercapnia (see Hypercapnia and Respiratory Failure)
- Physiology
- Hypercapnia-Associated Venodilation
- Physiology
- Hypoxemia (see Hypoxemia and Respiratory Failure)
- Physiology
- Hypoxia-Induced Systemic Vasodilation (Which Attempts to Maintain Tissue Perfusion with Oxygen Delivery)
- In Contrast, in the Pulmonary Circulation, Hypoxia Results in Hypoxic Pulmonary Vasoconstriction
- Hypoxia-Induced Systemic Vasodilation (Which Attempts to Maintain Tissue Perfusion with Oxygen Delivery)
- Physiology
- Pregnancy (see Pregnancy)
- Physiology
- Pregnancy-Associated Cardiovascular Changes
- Increased Heart Rate (by 10-20 Beats/Min)
- Increased Plasma Volume
- Increased Cardiac Output
- Increases Stroke Volume
- Decreased Blood Pressure
- Decreased Pulmonary Vascular Resistance (PVR)
- Decreased Systemic Vascular Resistance (SVR)
- Pregnancy-Associated Cardiovascular Changes
- Physiology
- Purpura Fulminans (see Purpura Fulminans)
- Clinical
- Fever (see Fever)
- Hypotension/Sepsis (see Sepsis)
- Large Purpuric Skin Lesions (see Purpura)
- Severe Disseminated Intravascular Coagulation (DIC) (see Disseminated Intravascular Coagulation)
- Clinical
- Systemic Arteriovenous Fistula (see Systemic Arteriovenous Fistula)
- Types
- Femoral Arteriovenous Fistula: most common type of acquired arteriovenous fistula (due to the frequency of using the femoral site for percutaneous arterial or venous access)
- Hemodialysis Arteriovenous Fistula (see Hemodialysis Arteriovenous Fistula)
- Physiology
- Peripheral Vasodilation
- Clinical
- High-Output Heart Failure May Occur
- Types
- Systemic Mastocytosis (see Systemic Mastocytosis)
- Physiology
- Peripheral Vasodilation
- Physiology
- Vasoplegic Syndrome (Post-Cardiac Surgery Vasodilation) (see Vasoplegic Syndrome)
- Physiology
- Peripheral Vasodilation Following Cardiac Surgery
- Physiology
- Vasovagal Syncope (see Vasovagal Syncope)
- Physiology
- Peripheral Vasodilation
- Physiology
Etiology of Increased Systemic Vascular Resistance (SVR)
Endocrinologic
- Pheochromocytoma (see Pheochromocytoma)
- Physiology
- Secretion of Adrenergic Substances
- Physiology
Drug/Toxin-Associated Vasoconstriction
- Bites/Stings
- Widow Spider Bite (see Widow Spider Bite)
- Epidemiology
- Hypertension is More Characteristically Seen in Widow Spider Bites
- Hypotension Occurs Rarely
- Epidemiology
- Widow Spider Bite (see Widow Spider Bite)
- Caffeine (see Caffeine)
- Pharmacology:
- Cocaine Intoxication (see Cocaine)
- Pharmacology
- Vasoconstriction
- Pharmacology
- Dopamine (see Dopamine)
- Pharmacology
- Vasoconstriction
- Pharmacology
- Methamphetamine Intoxication (see Methamphetamine)
- Pharmacology
- Vasoconstriction
- Pharmacology
- Norepinephrine (Levophed) (see Norepinephrine)
- Pharmacology
- Vasoconstriction
- Pharmacology
- Phenylephrine (Neosynephrine) (see Phenylephrine)
- Pharmacology
- Vasoconstriction
- Pharmacology
- Terbutaline (Brethine) (see Terbutaline)
- Pharmacology
- XXXXX
- Pharmacology
- Vasopressin (see Vasopressin)
- Pharmacology
- Vasoconstriction
- Pharmacology
Pulmonary Vascular Resistance (PVR)
Calculation of Pulmonary Vascular Resistance (PVR) Using Pressures Measured from Swan-Ganz Catheter (see Swan-Ganz Catheter)
- Calculation Technique
- Pulmonary Vascular Resistance (PVR) is Calculated from the Mean Arterial Pressure (MAP), Central Venous Pressure (CVP), and Cardiac Output (CO)
- Unlike, Pulmonary Vascular Resistance, All Three of These Latter Parameters are Measured
- Pulmonary Vascular Resistance (PVR) is Calculated from the Mean Arterial Pressure (MAP), Central Venous Pressure (CVP), and Cardiac Output (CO)
- Equation: PVR = [(PA Mean – PCWP)/CO] x 80
- Normal PVR Values (using dynes-sec/cm5): 20-120 dynes-sec/cm5
- Note: PVR normal values can alternatively be expressed as 0.25–1.6 Woods units (or 0.25–1.6 mm Hg-min/L) -> to convert from Woods units to dynes-sec/cm5, multiply by 80
Etiology of Increased Pulmonary Vascular Resistance (PVR)
- Very Low Lung Volume/Atelectasis (see Atelectasis)
- Mechanism
- Capillaries are Compressed, Increasing Pulmonary Vascular Resistance (PVR)
- Mechanism
- High Lung Volume/High Plateau Pressure (see Acute Respiratory Distress Syndrome)
- Mechanism
- Capillaries are Stretched (Decreasing Their Caliber), Increasing the Pulmonary Vascular Resistance (PVR)
- Mechanism
- Hypercapnia (see Hypercapnia)
- Mechanism
- Hypoxemia (see Hypoxemia)
- Mechanism
- Pulmonary Vasoconstriction
- Hypoxic Pulmonary Vasoconstriction is Enhanced by Acidosis
- Mechanism
- Pulmonary Hypertension (see Pulmonary Hypertension)
Central Venous Pressure (CVP)
Physiologic Determinants of Central Venous Pressure
- Atrial and Ventricular Compliance
- Right Ventricular (RV) Function
- Venous Return
Measurement of Central Venous Pressure (CVP)
- Central Venous Pressure is Transduced from the Distal (End) Port of a Central Venous Catheter (CVC) or Peripherally Inserted Central Catheter (PICC) (see Central Venous Catheter and Peripherally Inserted Central Catheter)
- Distal Port is Traditionally Located in Either the Superior Vena Cava (or the Right Atrium)
Clinical Efficacy Data
Clinical Efficacy-Measurement of Central Venous Pressure (CVP) Via a Peripherally Inserted Central Catheter (PICC) (see Peripherally Inserted Central Catheter)
- General Comments
- Peripherally Inserted Central Catheter (PICC) Has a Longer Length and a Narrower Lumen than a Central Venous Catheter (CVC)
- Peripherally Inserted Central Catheter (PICC) has a Higher Intrinsic Resistance than a Central Venous Catheter (CVC)
- Central Venous Pressure (CVP) Monitoring is an Indicated Use by Several Commercially Available Peripherally Inserted Central Catheters (PICC’s)
- AngioDynamics
- Arrow
- Bard
- Medcomp
- Peripherally Inserted Central Catheter (PICC) Has a Longer Length and a Narrower Lumen than a Central Venous Catheter (CVC)
- Early Study Comparing Central Venous Pressure (CVP) Obtained from Central Venous Catheters (CVC’s) and Peripherally Inserted Central Catheters (PICC’s) (2000) [MEDLINE]: study used 77 data pairs from 12 patients with measurements recorded at end-expiration in 19-gauge double-lumen peripherally inserted central catheters (PICC’s) (zeroed at the right atrium)
- Peripherally Inserted Central Catheters (PICC’s) Used in This Study Did Not Have High Infusion Rate Capability
- To Overcome the Higher Intrinsic Resistance of the Peripherally Inserted Central Catheter (PICC), a Continuous Infusion Device was Used with Heparinized Saline at 3 mL/hr (as is Commonly Used for Arterial Lines)
- Central Venous Pressure (CVP) Recorded from a Peripherally Inserted Central Catheter (PICC) is About 1 mm Hg Higher than that Obtained from Central Venous Pressure (CVP) Recorded from a Central Venous Catheter (CVC) (This Difference is Believed to Be Clinically Insignificant)
- Peripherally Inserted Central Catheters (PICC’s) Can Be Used to Measure Central Venous Pressure (CVP), Provided that Continuous Infusion Device is Used with Heparinized Saline
- Operative Study During AAA Repair Comparing Central Venous Pressure (CVP) Obtained from Central Venous Catheters (CVC’s) and Peripherally Inserted Central Catheters (PICC’s) (2006) [MEDLINE]
- Peripherally Inserted Central Catheters (PICC’s) are an Effective Method for Central Venous Pressure (CVP) Monitoring in Situations of Dynamic Systemic Compliance and Preload, Such as During Elective AAA Repair
- In Vitro Study Comparing CVP Obtained from Central Venous Catheters (CVC’s) and Peripherally Inserted Central Catheters (PICC’s) (2010) [MEDLINE]: in vitro study of AngioDynamics Morpheus Peripherally Inserted Central Catheter (PICC)
- Unlike Other Peripherally Inserted Central Catheters (PICC) Models, the Morpheus Peripherally Inserted Central Catheter (PICC) Shaft Has a Stiff Proximal End with a Softer Distal End
- The Stiff Proximal End Decreases Intraluminal Resistance, Prevents Compression by Soft Tissues Prior to Vessel Entry, and Prevents Compression of the Catheter in Region of the Subclavian Vein (Which is a Known Compression Site for Vascular Catheters)
- AngioDynamics Morpheus Peripherally Inserted Central Catheter (PICC) was Equivalent to Central Venous Catheter (CVC) When Measuring Central Venous Pressure (CVP)
- Unlike Other Peripherally Inserted Central Catheters (PICC) Models, the Morpheus Peripherally Inserted Central Catheter (PICC) Shaft Has a Stiff Proximal End with a Softer Distal End
- Korean Study Utilizing Peripherally Inserted Central Catheter (PICC) and Central Venous Pressure (CVP) Measurements During Liver Transplantation (2011) [MEDLINE]: study using double-lumen Arrow Peripherally Inserted Central Catheter (PICC)
- Peripherally Inserted Central Catheter (PICC was a Viable alternative to Central Venous Catheter (CVC) for Central Venous Pressure (CVP) Measurement During Liver Transplantation
- In Vitro and In Vivo Study Comparing Central Venous Pressure (CVP) Obtained from Central Venous Catheter (CVC) and Peripherally Inserted Central Catheter (PICC) (2012) [MEDLINE]: study used triple and double-lumen Bard PowerPICC’s (with high infusion rate capability) vs central venous catheter (CVC) in in vitro (540 pressure measurements) and in vivo (70 pressure measurements) protocols
- Peripherally Inserted Central Catheter (PICC) was Equivalent to Central Venous Catheter (CVC) When Measuring Central Venous Pressure (CVP) in Intensive Care Unit (ICU) Patients
Clinical Efficacy-Utility of Central Venous Pressure (CVP) to Assess Volume Status and Volume Responsiveness
- Systematic Review of Clinical Utility of Central Venous Pressure (CVP) (Chest, 2008) [MEDLINE]
- Systematic Review of 24 Studies (Which Studied Either the Relationship Between Central Venous Pressure (CVP) and Blood Volume or Reported the Associated Between Central Venous Pressure (CVP)/Delta Central Venous Pressure (CVP) and the Change in Stroke Volume/Cardiac Index Following a Fluid Challenge)
- There was a Very Poor Relationship Between Central Venous Pressure (CVP) and Blood Volume, as Well as the Inability of Central Venous Pressure (CVP)/Delta Central Venous Pressure (CVP) to Predict the Hemodynamic Response to a Fluid Challenge
- Despite Widely-Used Clinical Guidelines Recommending the Use of Central Venous Pressure (CVP), the Central Venous Pressure (CVP) Should Not Be Used to Make Clinical Decisions Regarding Fluid Management
- Meta-Analysis of Central Venous Pressure to Predict Fluid Responsiveness (Crit Care Med, 2013) [MEDLINE]: n= 43 studies (healthy adult controls n = 1, intensive care unit patients n = 22, and operating room patients n = 20)
- Overall 57% ± 13% of the Patients were Fluid Responders
- Summary Area Under the Curve was 0.56 (95% CI: 0.54-0.58) with No Heterogenicity Between the Studies
- Summary Area Under the Curve was 0.56 (95% CI: 0.52-0.60) for Those Studies Done in the Intensive Care Unit and 0.56 (95% CI: 0.54-0.58) for Those Studies Done in the Operating Room
- Summary Correlation Coefficient Between the Baseline Central Venous Pressure and Change in Stroke Volume Index/Cardiac Index was 0.18 (95% CI: 0.1-0.25), Being 0.28 (95% CI: 0.16-0.40) in the Intensive Care Unit Patients and 0.11 (95% CI: 0.02-0.21) in the Operating Room Patients
- There are No Data to Support the Widespread Practice of Using Central Venous Pressure to Guide Fluid Therapy
- Systematic Review Examining CVP in Predicting Fluid Responsiveness in Critically Ill Patients (Intensive Care Med, 2016) [MEDLINE]: n = 1148 (51 studies)
- Central Venous Pressure (CVP) was Subgrouped into Low (<8 mmHg), Intermediate (8-12 mmHg), High (>12 mmHg) Baseline Central Venous Pressure (CVP)
- Although Authors Identified Some Positive and Negative Predictive Values for Fluid Responsiveness for Specific Low and High Values of Central Venous Pressure (CVP), Respectively, None of the Predictive Values were >66% for Any Central Venous Pressure (CVP) from 0 to 20 mm Hg
- Central Venous Pressure (CVP) in the Normal Range Does Not Predict Fluid Responsiveness
Recommendations (2016 Surviving Sepsis Guidelines; Intensive Care Med, 2017) [MEDLINE] (Intensive Care Med, 2014) [MEDLINE]
- Use of Central Venous Pressure (CVP) Alone to Guide Resuscitation is Not Recommended in Sepsis
Pulmonary Capillary Wedge Pressure (PCWP)
Measurement Technique
- PCWP is Measured from the Swan-Ganz Catheter with the Balloon Inflated and “Wedged” in a Pulmonary Artery Branch (see Swan-Ganz Catheter)
- By Convention, PCWP is Measured at End-Expiration, Where the Extravascular (i.e. Pleural Pressure) is Zero
- Assuming Passive Inspiration/Expiration (Indicated by a Zero Slope of the PCWP Waveform) in a Spontaneously-Breathing Patient, End-Expiration Occurs at the “Peak” of the PCWP Waveform
- Assuming Passive Inspiration/Expiration (Indicated by a Zero Slope of the PCWP Waveform) in a Mechanically-Ventilated Patient, End-Expiration Occurs in the “Valley” of the PCWP Waveform (“Vent = Valley”)
- In a Patient Who is Actively Expiring, PCWP Waveform Will Have a Positive (Upward) Slope: in this case, it is impossible to determine an accurate PCWP without an esophageal balloon to measure the actual pleural pressure (since pleural pressure is not zero at end-expiration)
- By Convention, PCWP is Measured at End-Expiration, Where the Extravascular (i.e. Pleural Pressure) is Zero
- Using the Airway Pressure Tracing to Correctly Identify End-Expiration, at Which the Pulmonary Capillary Wedge Pressure Should Be Measured
- Study Attempting to Improve Inter-Observer Agreement of PCPW Readings Using Airway Pressure in ARDS (Crit Care Med, 2005) [MEDLINE]
- When Using a Standard Protocol Using Airway Pressure to Identify End-Expiration in the Tracing, PCWP Reading Agreement (within 2 mm Hg) Improved from 71% without Use of the Airway Pressure to 83% with Use of the Airway Pressure
- Inter-Observer Agreement was Higher for Strips Demonstrating >8 mm Hg in Phasic Respiratory Variation
- Study Attempting to Improve Inter-Observer Agreement of PCPW Readings Using Airway Pressure in ARDS (Crit Care Med, 2005) [MEDLINE]
Correction of Pulmonary Capillary Wedge Pressure Correction for Applied PEEP
- Change Units of PEEP to mm Hg by Dividing the Amount by 1.3
- Correct by Subtracting 33-50% of PEEP from the PCWP
Left Atrial End-Diastolic Pressure (LA-EDP)
- Measurement Technique: measured with (left-sided) cardiac catheterization
- Normal: 5-12 mm Hg
Oxygen Delivery and Consumption
Central Venous O2 Saturation (ScvO2)
General Comments
- Source of ScvO2: SaO2 sampled from SVC, with CVC tip above the RA
- Normal ScvO2: 65-80% (usually around 70%)
- ScvO2 is Usually Slightly Higher Than the SvO2: as ScvO2 is sampled at a point where venous blood from the coronary sinus has not mixed in yet (however, ScvO2 and SvO2 trend together)
Etiology of Increased ScvO2 (Decreased Oxygen Demand or Increased Oxygen Supply)
- Cyanide Intoxication (see Cyanide): due to decreased tissue extraction
- High pO2
- Hypothermia (see Hypothermia): due to decreased tissue metabolic rate
- L->R Intracardiac Shunt (see Intracardiac and Extracardiac Shunt): oxygenated blood is shunted from L->R
- Sepsis (see Sepsis): due to effective “shunting” with resultant decreased tissue extraction
- Severe Mitral Regurgitation (see Mitral Regurgitation,)
Etiology of Decreased ScvO2 (Insufficient Oxygen Delivery or Increased Oxygen Demand)
- Low Cardiac Output States
- Cardiogenic Shock
- Hypovolemic Shock
- R->L Intracardiac Shunt (see Intracardiac and Extracardiac Shunt): deoxygenated blood is shunted from R->L
Institute for Healthcare Improvement (IHI) Sepsis Goal-Directed Therapy Targets for ScvO2
- Target: ScvO2 >70%
- Target: CVP >8 (target: CVP>12 in mechanically ventilated patients and those with increased abdominal pressure)
- Target: Hct >30
Mixed Venous O2 Saturation (SvO2)
General Comments
- Source of SvO2: SaO2 sampled from Swan-distal port
- Normal SvO2: 68-77%
- ScvO2 is Usually Slightly Higher Than the SvO2: as ScvO2 is sampled at a point where venous blood from the coronary sinus has not mixed in yet (however, ScvO2 and SvO2 trend together)
Etiology of Increased SvO2 (Decreased Oxygen Demand or Increased Oxygen Supply)
- Cyanide Intoxication (see Cyanide): due to decreased tissue extraction
- High pO2
- Hypothermia (see Hypothermia): due to decreased tissue metabolic rate
- L->R Intracardiac Shunt (see Intracardiac and Extracardiac Shunt): oxygenated blood is shunted from L->R
- Sepsis (see Sepsis): due to effective “shunting” with resultant decreased tissue extraction
- Severe Mitral Regurgitation (see Mitral Regurgitation)
Etiology of Decreased SvO2 (Insufficient Oxygen Delivery or Increased Oxygen Demand)
- Low Cardiac Output State
- Cardiogenic Shock
- Hypovolemic Shock
- R->L intracardiac shunt (see Intracardiac and Extracardiac Shunt): deoxygenated blood is shunted from R->L
Institute for Healthcare Improvement (IHI) Sepsis Goal-Directed Therapy Targets for SvO2
- Target: SvO2 >65%
- Target: CVP >8 (target: CVP>12 in mechanically ventilated patients and those with increased abdominal pressure)
- Target: Hct >30
Arterial Oxygen Content
Most of the Oxygen Which Diffuses from the Alveolus into the Blood is Bound by Hemoglobin
- The Amount of Oxygen Dissolved in Plasma is Generally Small Relative to the Amount of Oxygen Bound to Hemoglobin, But Becomes Significant at Very High pO2 (as in a Hyperbaric Chamber) or in Severe Anemia
- The Constant 0.0031 in the Arterial Oxygen Content Represents the Amount of Oxygen Dissolved in the Plasma
- Because this Amount is Relatively Small, the pO2 Term is Commonly Omitted from the Arterial Oxygen Content Equation (as We Do Below)
- Under Normal Conditions, Complete Oxygenation of the Blood Occurs in 0.25 sec (This is Approximately One Third of the Total Time that the Blood is in Contact with the Alveolar-Capillary Membrane)
- This Rapid Diffusion Normally Allows the System to Sufficiently Compensate for Any Impairment in Oxygen Diffusion
- In Dyshemoglobinemias (Such as Sickle Cell Disease, etc), the Arterial Oxygen Content is Calculated with the Same Equation as Below, Although the Saturations (and Therefore, the Oxygen Content) Will Be Different for a Specific pO2 (Pediatr Pulmonol, 1999) [MEDLINE]
Arterial Oxygen Content Equation
- Arterial Oxygen Content = [Hb x 13.4 x SaO2 + (0.0031 x pO2)]
- Hemoglobin (Hb): in g/dL
- Constant 13.4: accounts for the fact that 1.34 ml of O2 is carried per g of Hb (13.4 is used in the equation to correct the units from dL to L)
- Arterial Oxygen Saturation (SaO2): as a decimal
- pO2: in mm Hg
- Normal Arterial Oxygen Content: approximately 200 mL O2/L (or 20 mL O2/dL)
- This Equation Will Yield the Arterial Oxygen Content in mL O2/L, Which Allows the Arterial Oxygen Content Value to Be Plugged into the Oxygen Delivery Equation Below without Unit Conversion
- Simplified Arterial O2 Content (Omitting the pO2 Term) Arterial O2 Content = [Hb x 13.4 x (SaO2)]
Oxygen Delivery Equation
- Definition: rate at which oxygen is transported from the lungs to the tissues
- Using a Train Analogy
- Hb = number of boxcars
- SaO2= how full the boxcars are
- CO = how fast the train is going
- Using a Train Analogy
- O2 Delivery = CO x Arterial O2 Content x 10 = CO x [Hb x 1.34 x SaO2] x 10
- CO: in L/min
- Hb: in g/dL
- SaO2: as decimal
- Factor of 10 in the Equation Converts Everything to mL
- Normal (Using Cardiac Output): 1000 mL/min
- Normal (Using Cardiac Index): 500 mL/min/m2
Oxygen Consumption Equation
- Oxygen Consumption = CO x [Hb x 1.34 x (SaO2-SvO2)]
- Hb: in g/dL
- SaO2: as decimal
- SvO2: as decimal
- Normal (Using Cardiac Output): 250 mL/min
- Normal (Using Cardiac Index): 110-130 mL/min/m2
Fick Equation
- Fick Cardiac Output = Oxygen Consumption/(10 x Arteriovenous O2 Difference)
- Fick Cardiac Output = Oxygen Consumption/(10 x Arterial Oxygen Content – Venous Oxygen Content)
- Fick Cardiac Output = 250/[(Hb x 13.4 x SaO2) – (Hb x 13.4 x SvO2)]
- Oxygen Consumption: this equation assumes the oxygen consumption is approximately 250 mL/min (or determined by respirometry or a nomogram)
- Arteriovenous O2 Difference: in mL O2/dL
- Hemoglobin (Hb): in g/dL
- Arterial Oxygen Saturation (SaO2): as a decimal
- Venous Oxygen Saturation (SaO2): as a decimal
Oxygen Extraction Ratio
- Oxygen Extraction Ratio = [O2 Consumption/O2 Delivery] x 100
- Normal: 23-32% (interpretation: only 20-30% of oxygen delivered is taken up by tissues)
- Etiology of Increased Oxygen Extraction Ratio
- Low Cardiac Output State
- Cardiogenic Shock
- Hypovolemic Shock
- Low Cardiac Output State
- Etiology of Decreased Oxygen Extraction Ratio
- Sepsis (see Sepsis): due to peripheral shunting and decreased tissue extraction
- Hepatopulmonary Syndrome (see Hepatopulmonary Syndrome): due to high CO + low SVR state seen in cirrhosis
Hemodynamic Patterns
High Cardiac Output + Low Systemic Vascular Resistance Pattern (with Normal Pulmonary Capillary Wedge Pressure and Central Venous Pressure)
Conditions with Predominant Peripheral Vascular Effects
- Carcinoid Syndrome (see Carcinoid Syndrome)
- Cirrhosis/Liver Disease (see Cirrhosis)
- Erythroderma (of Any Etiology) (see Erythroderma)
- Morbid Obesity (see Obesity)
- Clinical
- High Cardiac Output (Although Cardiac Output is Normal When Adjusted for Body Weight)
- Clinical
- Systemic Arteriovenous Fistula (AVF) (see Systemic Arteriovenous Fistula)
Conditions with Predominant Metabolic Effects
- Hyperthyroidism (see Hyperthyroidism)
- Myeloproliferative Disorders with Extramedullary Hematopoiesis
Conditions with Myocardial and Peripheral Vascular Effects
- Acromegaly (see Acromegaly)
- Anagrelide (Agrylin, Xagrid) (see Anagrelide)
- Dobutamine (Dobutrex) (see Dobutamine)
- Milrinone (see Milrinone)
- Mitochondrial Disease
- Sepsis (see Sepsis)
- Thiamine (Vitamin B1) Deficiency (Beriberi) (see Thiamine)
Other
- Anaphylaxis (see Anaphylaxis)
- Anemia (Chronic, Severe) (see Anemia)
- Chronic Pulmonary Disease (with Hypoxemia and/or Hypercapnia)
- Exercise
- Fever (see Fever)
- Hot Climate
- Pregnancy (see Pregnancy)
Equalization of Central Venous Pressure + Right Ventricular-Diastolic + Pulmonary Artery-Diastolic + Pulmonary Capillary Wedge Pressure
- Tamponade (see Tamponade)
“Right Ventricular Restrictive” Pattern (Equalization of Central Venous Pressure/Right Ventricular-Diastolic/Pulmonary Artery-Diastolic + Low-Normal Pulmonary Capillary Wedge Pressure)
- Right Ventricular Infarct (see Coronary Artery Disease)
- Right Ventricular Infarct Occurs in Association with Inferior Wall Myocardial Infarction
Hypovolemic/Hemorrhagic Shock Pattern = Low Central Venous Pressure + Low Pulmonary Capillary Wedge Pressure + Low Cardiac Output + High Systemic Vascular Resistance
- Hypovolemic Shock (see see Hypovolemic Shock)
- Hemorrhagic Shock (see Hemorrhagic Shock)
Cor Pulmonale Pattern = High Central Venous Pressure + Normal Pulmonary Capillary Wedge Pressure + Low Cardiac Output + High Pulmonary Vascular Resistance
- Pulmonary Hypertension (see Pulmonary Hypertension)
Left Heart Failure Pattern = High Central Venous Pressure + High Pulmonary Capillary Wedge Pressure + Low Cardiac Output + Normal Pulmonary Vascular Resistance
- Left Heart Failure (see Congestive Heart Failure)
SaO2 “Step-Up” of >5% from Right Atrium to Pulmonary Artery
- Ventricular Septal Defect (VSD) with L-R Shunt (see Ventricular Septal Defect)
- Atrial Septal Defect (ASD) with L->R Shunt (see Atrial Septal Defect)
- Patent Foramen Ovale (PFO) with L->R Shunt (see Patent Foramen Ovale)
- Ruptured Sinus of Valsalva Aneurysm with Aortic->RA or Aortic->RV Shunt (see Sinus of Valsalva Aneurysm)
Large v-Waves on Pulmonary Capillary Wedge Pressure Tracing
- Mitral Regurgitation (MR) (see Mitral Regurgitation)
- Ventricular Septal Defect (VSD) (see Ventricular Septal Defect)
- Ventricular Septal Rupture (see Ventricular Septal Rupture)
References
General
- Plasma volume expansion in surgical patients with high central venous pressure: the relationship of blood volume to hematocrit, CVP, pulmonary wedge pressure and cardiorespiratory changes. Surg 1975;78:304-315 [MEDLINE]
- Critical level of oxygen delivery in anesthetized man. Crit Care Med 1983; 11:640 [MEDLINE]
- The effects of dopamine on cardiopulmonary function and left ventricular volumes in patients with acute respiratory failure. Am Rev Respir Dis 1984;130:396-399 [MEDLINE]
- Critical level of oxygen delivery after cardiopulmonary bypass. Crit Care Med 1987; 15:194 [MEDLINE]
- Measurement of hemoglobin saturation by oxygen in children and adolescents with sickle cell disease. Pediatr Pulmonol. 1999;28(6):423 [MEDLINE]
- Human pulmonary vascular response to 4 h of hypercapnia and hypocapnia measured using Doppler echocardiography. J Appl Physiol 2003, 94:1543-1551 [MEDLINE]
- Impact of acute hypercapnia and augmented positive end-expiratory pressure on right ventricle function in severe acute respiratory distress syndrome. Intensive Care Med 2009, 35:1850-1858 [MEDLINE]
- Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Crit Care. 2010;14(5):R169 [MEDLINE]
- Hemodynamic Monitoring for the Evaluation and Treatment of Shock: What Is the Current State of the Art? Semin Respir Crit Care Med. 2015 Dec;36(6):890-8. doi: 10.1055/s-0035-1564874. Epub 2015 Nov 23 [MEDLINE]
Mean Arterial Pressure
- Blood pressure measurement in shock. Mechanism of inaccuracy in ausculatory and palpatory methods. JAMA 1967: 199(13):118–122 [MEDLINE]
- Arterial catheters as a source of bloodstream infection: a systematic review and meta-analysis. Crit Care Med. 2014 Jun;42(6):1334-9. doi: 10.1097/CCM.0000000000000166 [MEDLINE]
Cardiac Output
- Hemodynamic studies in beriberi heart disease. Am J Med. 1966;41(2):197 [MEDLINE]
- Echocardiographic LV function in thyrotoxicosis. Am Heart J. 1979;97(4):460 [MEDLINE]
- The challenge of cardiomyopathy. J Am Coll Cardiol. 1989;13(6):1219 [MEDLINE]
- Metastatic carcinoid disease presenting solely as high-output heart failure. Ann Intern Med. 1994;120(1):45 [MEDLINE]
- Thyrotoxicosis-induced congestive heart failure in an urban hospital. Am J Med Sci. 1994;308(6):344 [MEDLINE]
- Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res 2000 Oct;48(1):23-33 [MEDLINE]
- High Output Cardiac Failure. Curr Treat Options Cardiovasc Med. 2001 Apr;3(2):151-159 [MEDLINE]
- Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7):501 [MEDLINE]
- Cardiovascular abnormalities in patients with a carcinoid syndrome. Neth J Med. 2002 Mar;60(1):10-6 [MEDLINE]
- Hyperthyroidism: a “curable” cause of congestive heart failure–three case reports and a review of the literature. Congest Heart Fail. 2003;9(1):40 [MEDLINE]
- Echocardiographic detection of intrapulmonary shunting in a patient with hepatopulmonary syndrome: case report and review of the literature. Echocardiography. 2006;23(1):56 [MEDLINE]
- Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism. Heart. 2007;93(4):483 [MEDLINE]
- Mechanisms in endocrinology: Heart failure and thyroid dysfunction. Eur J Endocrinol. 2012 Nov;167(5):609-18 [MEDLINE]
- Diet-induced obesity promotes altered remodeling and exacerbated cardiac hypertrophy following pressure overload. Physiol Rep. 2015;3(8) [MEDLINE]
- High-Output Heart Failure: A 15-Year Experience. J Am Coll Cardiol. 2016;68(5):473 [MEDLINE]
- Hyperdynamic Right Heart Function in Graves’ Hyperthyroidism Measured by Echocardiography Normalises on Restoration of Euthyroidism. Heart Lung Circ. 2017;26(6):580 [MEDLINE]
- Leptin-Aldosterone-Neprilysin Axis: Identification of Its Distinctive Role in the Pathogenesis of the Three Phenotypes of Heart Failure in People With Obesity. Circulation. 2018;137(15):1614 [MEDLINE]
- Acute Right Ventricular Heart Failure: An Uncommon Case of Thyrotoxicosis. Am J Med Sci. 2018;356(3):309 [MEDLINE]
Pulmonary Capillary Wedge Pressure
- Effect of airway pressure display on interobserver agreement in the assessment of vascular pressures in patients with acute lung injury and acute respiratory distress syndrome. Crit Care Med. 2005 Jan;33(1):98-103; discussion 243-4 [MEDLINE]
Central Venous Pressure (CVP)
- Central venous pressure measurements: peripherally inserted catheters versus centrally inserted catheters. Crit Care Med. 2000 Dec;28(12):3833-6 [MEDLINE]
- Intraoperative peripherally inserted central venous catheter central venous pressure monitoring in abdominal aortic aneurysm reconstruction. Ann Vasc Surg. 2006 Sep;20(5):577-81. Epub 2006 Jul 27 [MEDLINE]
- Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest. 2008 Jul;134(1):172-8. doi: 10.1378/chest.07-2331 [MEDLINE]
- An in vitro study comparing a peripherally inserted central catheter to a conventional central venous catheter: no difference in static and dynamic pressure transmission. BMC Anesthesiol. 2010 Oct 12;10:18. doi: 10.1186/1471-2253-10-18 [MEDLINE]
- Comparison of the central venous pressure from internal jugular vein and the pressure measured from the peripherally inserted antecubital central catheter (PICCP) in liver transplantation recipients. Korean J Anesthesiol. Oct 2011; 61(4): 281–287. Published online Oct 22, 2011. doi: 10.4097/kjae.2011.61.4.281 [MEDLINE]
- Peripherally inserted central catheters are equivalent to centrally inserted catheters in intensive care unit patients for central venous pressure monitoring. J Clin Monit Comput. 2012 Apr;26(2):85-90. doi: 10.1007/s10877-012-9337-1 [MEDLINE]
- Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 2014; 40(12):1795–1815 [MEDLINE]
- Systematic review including re‐analyses of 1148 individual data sets of central venous pressure as a predictor of fluid responsiveness. Intensive Care Med 2016, 42(3):324–332 [MEDLINE]
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017 Jan 18. doi: 10.1007/s00134-017-4683-6 [MEDLINE]